Letters
Harmful impact of EU clinical trials directive: Trial of alerting drug in fibromyalgia has had to be abandoned…
BMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7542.666 (Published 16 March 2006) Cite this as: BMJ 2006;332:666
- Christopher D Hanning, consultant in sleep medicine (chris.hanning@uhl-tr.nhs.uk),
- Patricia Rentowl, research assistant
- Leicester General Hospital, Leicester LE5 4PW
EDITOR—Hemminki and Kellokumpu-Lehtinen show the impact of the EU Clinical Trials Directive and the resulting additional cost and bureaucratic delays on cancer drug research.1 It has become almost impossible for academic researchers to initiate and …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.